Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.08 USD | +0.07% | +0.22% | -17.20% |
Apr. 24 | HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69 | MT |
Apr. 23 | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.20% | 83.65B | |
+25.61% | 660B | |
+23.23% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.62% | 219B | |
-9.65% | 196B | |
+6.66% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- RBC Capital Raises Gilead Sciences Price Target to $83 From $79, Maintains Outperform Rating